Liraglutide: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
<StructureSection load='4apd' size='340' side='right' caption='NMR structure of liraglutide. PDB entry [[4apd]]' scene='96/969657/Cv/1'> | <StructureSection load='4apd' size='340' side='right' caption='NMR structure of liraglutide. PDB entry [[4apd]]' scene='96/969657/Cv/1'> | ||
Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. See also [https://en.wikipedia.org/wiki/Liraglutide]. | Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. See also [https://en.wikipedia.org/wiki/Liraglutide]. | ||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
Revision as of 15:46, 13 June 2023
Liraglutide, sold under the brand name Victoza among others, is an anti-diabetic medication used to treat type 2 diabetes, and chronic obesity. See also [1].
|
| ||||||||||